Systems and methods for multiplex analysis of PCR in real time

• US 9,745,620 B2
• Filed: 10/16/2015
• Issued: 08/29/2017
• Est. Priority Date: 12/13/2006
• Status: Active Grant

• Current Assignee: Luminex Corporation (DiaSorin S.p.A.)
• Original Assignee: Luminex Corporation (DiaSorin S.p.A.)
• Inventors: Whitman, Douglas F., Collins, Charles J.
• Primary Examiner(s): THOMAS, DAVID C
• Application Number:
  US14/885,351
• Publication Number:
  US 20160032373A1
• Time in Patent Office: 683 Days
• Field of Search: None
• CPC Class Codes: C12Q 1/6804 Nucleic acid analysis using immunogens immunoassay G01N33/53
• CPC Class Codes: C12Q 1/6818 involving interaction of two or more labels, e.g. resonant energy transfer
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 2531/113 PCR
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2561/113 Real time assay
• CPC Class Codes: C12Q 2563/143 Magnetism, e.g. magnetic label

Abstract

The present invention provides methods and systems for real-time measurements of PCR with multiplexing capability. Certain embodiments relate to methods and systems that use fluorescently encoded superparamagnetic microspheres for the immobilization of amplification products during the PCR process, and an imaging chamber of a measurement device that is also capable of controllable thermal cycling for assisting the PCR process.

Claims

1. A method of detecting a target molecule in a sample comprising:

(a) forming a capture sandwich complex by binding a target molecule, if present in a sample, with (i) a capture antibody, and (ii) a detection antibody, wherein the capture antibody is linked to a magnetic particle and the detection antibody is linked to a detection nucleic acid sequence;

(b) applying a magnetic field to a surface of a chamber containing the capture antibody linked to the magnetic particle to draw the magnetic particle to the surface in order to immobilize the capture sandwich complex on the surface of the chamber, wherein the magnetic field is applied before or after the capture sandwich complex is formed;

(c) while the capture sandwich complex is immobilized on the surface of the chamber, washing the chamber to remove excess detection antibody from the chamber;

(d) introducing into the chamber a primer pair for priming amplification of the detection nucleic acid sequence, a labeling agent, and a probe complementary to an amplification product of the primer pair and the detection nucleic acid sequence, wherein the probe is immobilized on an encoded magnetic bead such that the identity of the probe is known from the encoded magnetic bead on which it is immobilized;

(e) performing an amplification cycle to form a labeled amplification product of the detection nucleic acid sequence amplified with the primer pair;

(f) hybridizing the labeled amplification product to the probe immobilized on the encoded magnetic bead; and

(g) detecting the target molecule, if present in the sample, by detecting a signal from the encoded magnetic bead and a signal from the labeled amplification product.

2. The method of claim 1, wherein the target molecule is a first target molecule, the capture antibody is a first capture antibody, the detection antibody is a first detection antibody, the detection nucleic acid sequence is a first detection nucleic acid sequence, the capture sandwich complex is a first capture sandwich complex, the primer pair is a first primer pair, the probe is a first probe, and the encoded magnetic bead is a first encoded magnetic bead, the method further comprising:

(a) forming a second capture sandwich complex by binding a second target molecule, if present in the sample, with (i) a second capture antibody, wherein the second capture antibody is linked to a magnetic particle, and (ii) a second detection antibody, wherein the second detection antibody is linked to a second detection nucleic acid sequence, and further wherein the second detection nucleic acid sequence is not identical to the first detection nucleic acid sequence;

(b) applying the magnetic field to the surface of the chamber containing the first capture antibody and the second capture antibody in order to immobilize the first and second capture sandwich complexes on the surface of the chamber;

(c) while the first and second capture sandwich complexes are immobilized on the surface of the chamber, washing the chamber to remove excess detection antibodies;

(d) introducing into the chamber first and second primer pairs for priming amplification of the first and second detection nucleic acid sequences, respectively, the labeling agent, and first and second probes complementary, respectively, to first and second amplification products of the first and second primer pairs and the first and second detection nucleic acid sequences, wherein the first probe is immobilized on the first encoded magnetic bead and the second probe is immobilized on a second encoded magnetic bead such that the identity of the first and second probes is known from the first and second encoded magnetic beads on which they are immobilized;

(e) performing an amplification cycle to form first and second labeled amplification products of the first and second detection nucleic acid sequences amplified with the first and second primer pairs;

(f) hybridizing the first and second labeled amplification products to the first and second probes immobilized on the first and second encoded magnetic beads; and

(g) detecting the first target molecule, if present in the sample, by detecting a signal from the first encoded magnetic bead and a signal from the first labeled amplification product, and detecting the second target molecule, if present in the sample, by detecting a signal from the second encoded magnetic bead and a signal from the second labeled amplification product.

3. The method of claim 1, wherein the target molecule is a protein.

4. The method of claim 1, wherein the magnetic field is applied to the chamber prior to forming the capture sandwich complex.

5. The method of claim 4, comprising (i) applying the magnetic field to the surface of a chamber containing the sample and the capture antibody in order to immobilize the target molecule bound to the capture antibody on the surface of the chamber, and (ii) prior to adding the detection antibody to the chamber, washing the chamber to remove excess sample, including excess target molecule from the chamber.

6. The method of claim 1, wherein the magnetic field is applied to the chamber after forming the capture sandwich complex.

7. The method of claim 1, wherein the labeling agent is a fluorescent dye.

8. The method of claim 1, wherein the labeling agent is a fluorophore and quencher pair.

9. The method of claim 1, wherein the labeling agent is a DNA intercalating agent.

10. The method of claim 1, wherein the encoded magnetic bead is encoded with one or more fluorescent dyes.

11. The method of claim 10, wherein the encoded magnetic bead is encoded with different fluorescent intensities of the one or more fluorescent dye.

12. The method of claim 1, further comprising removing the magnetic field after washing the chamber to remove excess detection antibody from the chamber, and re-applying the magnetic field prior to detecting the target molecule.

13. The method of claim 12, wherein the magnetic field is re-applied during a primer annealing phase of the amplification cycle.

14. The method of claim 12, wherein the magnetic field is re-applied during a primer extension phase of the amplification cycle.

15. The method of claim 12, wherein the magnetic field is re-applied following the amplification cycle.

16. The method of claim 1, wherein detecting the signal from the encoded magnetic beads and the signal from the labeled amplification products comprises imaging fluorescent wavelengths emitted from the encoded magnetic beads and the labeled amplification products.